๐
Prepandrix
prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
Influenza, Human;Immunization;Disease Outbreaks
๐ซ Withdrawn
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Active immunisation against H5N1 subtype of influenza-A virus. This indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of vaccine prepared with H5N1 subtype strains. Prepandrix should be used in accordance with official guidance.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/prepandrix